Navigation Links
Invention to prevent surgical adhesions wins Kaye Award
Date:6/12/2008

Jerusalem, June 12, 2008 A material designed to prevent adhesions following surgery has won for Hebrew University Prof. Daniel Cohn of the Casali Instititue of Applied Chemistry first prize in this year's Kaye Awards for Innovation. The awards were presented during the recent 71st meeting of the Hebrew University Board of Governors.

Prof. Cohn has developed a unique polymer (compounds of high molecular weight) that generate a physical barrier between layers of injured tissues, preventing the formation of adhesions between opposing tissue planes.

Adhesions are abnormal bands of scar tissue that form post-operatively in the treated area and cause organs to bind to one another. Typically, adhesions persist long after the original trauma has healed, attaching organs, nerves, muscles and other neighboring structures. They are formed in approximately 85% of all patients undergoing routine surgical procedures and represent a major source of post-operative complications and deaths.

The generation of adhesions following heart surgery is of special concern, since they may affect cardiac function. Furthermore, in the frequent cases where repeat operations are required, adhesions obscure cardiac landmarks, making the procedure potentially life-threatening to the patient due to inadvertent vascular or cardiac injury.

Already in use is a wide variety of polymers which are foreign to the human body and which are used in direct contact with its organs, tissues and fluids. These materials are called biomedical polymers, and they have contributed significantly to modern medicine. The barrier created by the preventive polymers is required to remain in place for the period during which the adhesions are generated (a few days), and then, gradually degrade and disappear without having any detrimental effect. Additional requirements pertain to handling and suturing properties of the polymeric film..

The significant step forward represented by Prof. Cohn's invention lies in the development of a new family of biodegradable copolymers, which are combinations of two different monomers (low molecular weight molecules). These copolymers combine two types of segments, each of them rendering the polymers with specific properties. This multicomponent approach permits the variance of various parameters of the materials -- adjusting their basic chemistry, composition and molecular weight -- to comply with the clinical requirements of each specific surgical application.

Prof. Cohn's invention of novel tailor-made biodegradable polymers for the prevention of post-surgical adhesions is patented by Yissum, the Technology Transfer Company of the Hebrew University of Jerusalem. SyntheMed Inc. licensed the technology from Yissum and is awaiting an FDA marketing approval for the first product, REPEL-CV Adhesion Barrier, for use in pediatric patients (21 and younger) who are likely to need secondary open heart surgery. REPEL-CV has European CE Mark approval for use in all cardiac surgery patients and is currently marketed in most European Union countries.


'/>"/>

Contact: Jerry Barach
jerryb@savion.huji.ac.il
972-258-82904
The Hebrew University of Jerusalem
Source:Eurekalert  

Related medicine news :

1. Invention gives improved gene technology analysis
2. Surgery looks at inventions and innovations by surgeons
3. Endu Receives Gold Medal for Outstanding Chinese Patented Invention Award
4. CleanRest(R) Announces a Groundbreaking Invention, The Worlds Cleanest Pillow(TM)
5. World-renowned bioengineers to record history of medical inventions
6. Time Magazine Names Agendia Test a Best Invention of 2007
7. Gender affects reaction to HIV-prevention materials
8. Linkwell Corporation Disinfection Epidemic Prevention Teams Enter into Sichuan Earthquake Area
9. Antibiotics can prevent wound complications of childbirth, Stanford/Packard study finds
10. Drug Regimen Prevents AIDS Transmission Via Breast Milk
11. Worlds Leading Health Experts Urge Countries to Use Newly Released Data to Prevent the Death of Millions of Children Due to Rotavirus
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Invention to prevent surgical adhesions wins Kaye Award
(Date:2/5/2016)... ... 05, 2016 , ... Francisco Canales, MD and Heather Furnas, ... Valley office. The technique utilizes the body’s own healing abilities to quickly rejuvenate ... are part of only a select few cosmetic surgeons bringing this procedure to ...
(Date:2/5/2016)... ... February 05, 2016 , ... After years as an active ... Unit, plastic and cosmetic surgeon Dr. Wayne Carman transitioned to chief of the Division ... completed his first three-year term as chief and began a second three-year term in ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... PROSHRED franchises from across the country gathered at the La Valencia Hotel in ... performers. PROSHRED Chicago was named the year’s most outstanding franchise, walking away ...
(Date:2/5/2016)... ... 05, 2016 , ... Give To Cure today announced that it ... to Give To Cure’s campaign that is crowdfunding clinical trials to help find cures ... payments through a smart device. In 2015 alone, Venmo processed $7.5 billion in transactions ...
(Date:2/5/2016)... ... February 05, 2016 , ... At its annual meeting held ... as Chairman of the National Board of Directors. Mr. McDermott succeeds former APDA Chairman, ... stated Leslie A. Chambers , APDA President and CEO. “Pat has tirelessly served ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... Feb. 5, 2016 Aethlon Medical, Inc. (Nasdaq: ... and CEO, will be presenting at Source Capital Group,s 2016 ... NY at 2:15 p.m. ET on Wednesday, February ... Panel discussion taking place at 3:15 p.m. ET. ... one hour after the conclusion of the live event. The ...
(Date:2/5/2016)... , February 5, 2016 ... Market Research report states that the global active pharmaceuticals ... and is predicted to reach US$185.9 bn by 2020. ... 6.50% from 2014 to 2020. The title of the ... Captive/Contract Manufactured, by Geography, and by Therapeutic Area) - ...
(Date:2/5/2016)... , Feb. 5, 2016  Zimmer Biomet Holdings, Inc. ... the previously announced underwritten secondary offering of 11,027,558 shares ... consisting of affiliates of Blackstone and Goldman Sachs.  The ... initial price of $96.45 per share. The selling stockholders ...  Neither Zimmer Biomet nor any of its directors, officers ...
Breaking Medicine Technology: